The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders

  1. Cheen Euong Ang
  2. Qing Ma
  3. Orly L Wapinski
  4. ShengHua Fan
  5. Ryan A Flynn
  6. Qian Yi Lee
  7. Bradley Coe
  8. Masahiro Onoguchi
  9. Victor Hipolito Olmos
  10. Brian T Do
  11. Lynn Dukes-Rimsky
  12. Jin Xu
  13. Koji Tanabe
  14. LiangJiang Wang
  15. Ulrich Elling
  16. Josef M Penninger
  17. Yang Zhao
  18. Kun Qu
  19. Evan E Eichler
  20. Anand Srivastava
  21. Marius Wernig  Is a corresponding author
  22. Howard Y Chang  Is a corresponding author
  1. Stanford University, United States
  2. Greenwood Genetic Center, United States
  3. Howard Hughes Medical Institute, University of Washington, United States
  4. Clemson University, United States
  5. Institute of Molecular Biotechnology of the Austrian Academy of Science, Austria

Abstract

Long noncoding RNAs (lncRNAs) have been shown to act as important cell biological regulators including cell fate decisions but are often ignored in human genetics. Combining differential lncRNA expression during neuronal lineage induction with copy number variation morbidity maps of a cohort of children with autism spectrum disorder/intellectual disability versus healthy controls revealed focal genomic mutations affecting several lncRNA candidate loci. Here we find that a t(5:12) chromosomal translocation in a family manifesting neurodevelopmental symptoms disrupts specifically lnc-NR2F1. We further show that lnc-NR2F1 is an evolutionarily conserved lncRNA functionally enhances induced neuronal cell maturation and directly occupies and regulates transcription of neuronal genes including autism-associated genes. Thus, integrating human genetics and functional testing in neuronal lineage induction is a promising approach for discovering candidate lncRNAs involved in neurodevelopmental diseases.

Data availability

Sequencing data have been deposited in GEO under accession code GSE115079.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Cheen Euong Ang

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Qing Ma

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Orly L Wapinski

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. ShengHua Fan

    J C Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ryan A Flynn

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Qian Yi Lee

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9200-0910
  7. Bradley Coe

    Department of Genome Sciences, Howard Hughes Medical Institute, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Masahiro Onoguchi

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Victor Hipolito Olmos

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Brian T Do

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Lynn Dukes-Rimsky

    J C Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Jin Xu

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0944-9835
  13. Koji Tanabe

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. LiangJiang Wang

    Department of Genetics and Biochemistry, Clemson University, Clemson, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Ulrich Elling

    Vienna Biocenter, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  16. Josef M Penninger

    Vienna Biocenter, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8194-3777
  17. Yang Zhao

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Kun Qu

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Evan E Eichler

    Department of Genome Sciences, Howard Hughes Medical Institute, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8246-4014
  20. Anand Srivastava

    J C Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, United States
    Competing interests
    The authors declare that no competing interests exist.
  21. Marius Wernig

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    For correspondence
    wernig@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.
  22. Howard Y Chang

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    For correspondence
    howchang@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9459-4393

Funding

NIH Office of the Director (RC4-NS073015)

  • Marius Wernig
  • Howard Y Chang

NIH Office of the Director (P50-HG007735)

  • Howard Y Chang

California Institute for Regenerative Medicine

  • Marius Wernig
  • Howard Y Chang

NIH Office of the Director (RO1-HD39331)

  • Anand Srivastava

Self Regional Healthcare Foundation

  • Anand Srivastava

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mouse work was performed according to IACUC approved protocols at Stanford University (APLAC-21565). Samples in the paper were obtained without determining their sex. All animals were housed in an animal facility with a 12hr light/dark cycle.

Human subjects: The study protocol, consent form, consent to publish and privacy practices were reviewed and approved by the Institutional Review Board of the Self Regional Healthcare, Greenwood, SC (Reference number Pro00074882).

Copyright

© 2019, Ang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,544
    views
  • 876
    downloads
  • 61
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Cheen Euong Ang
  2. Qing Ma
  3. Orly L Wapinski
  4. ShengHua Fan
  5. Ryan A Flynn
  6. Qian Yi Lee
  7. Bradley Coe
  8. Masahiro Onoguchi
  9. Victor Hipolito Olmos
  10. Brian T Do
  11. Lynn Dukes-Rimsky
  12. Jin Xu
  13. Koji Tanabe
  14. LiangJiang Wang
  15. Ulrich Elling
  16. Josef M Penninger
  17. Yang Zhao
  18. Kun Qu
  19. Evan E Eichler
  20. Anand Srivastava
  21. Marius Wernig
  22. Howard Y Chang
(2019)
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders
eLife 8:e41770.
https://doi.org/10.7554/eLife.41770

Share this article

https://doi.org/10.7554/eLife.41770

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Iti Mehta, Jacob B Hogins ... Larry Reitzer
    Research Article

    Polyamines are biologically ubiquitous cations that bind to nucleic acids, ribosomes, and phospholipids and, thereby, modulate numerous processes, including surface motility in Escherichia coli. We characterized the metabolic pathways that contribute to polyamine-dependent control of surface motility in the commonly used strain W3110 and the transcriptome of a mutant lacking a putrescine synthetic pathway that was required for surface motility. Genetic analysis showed that surface motility required type 1 pili, the simultaneous presence of two independent putrescine anabolic pathways, and modulation by putrescine transport and catabolism. An immunological assay for FimA—the major pili subunit, reverse transcription quantitative PCR of fimA, and transmission electron microscopy confirmed that pili synthesis required putrescine. Comparative RNAseq analysis of a wild type and ΔspeB mutant which exhibits impaired pili synthesis showed that the latter had fewer transcripts for pili structural genes and for fimB which codes for the phase variation recombinase that orients the fim operon promoter in the ON phase, although loss of speB did not affect the promoter orientation. Results from the RNAseq analysis also suggested (a) changes in transcripts for several transcription factor genes that affect fim operon expression, (b) compensatory mechanisms for low putrescine which implies a putrescine homeostatic network, and (c) decreased transcripts of genes for oxidative energy metabolism and iron transport which a previous genetic analysis suggests may be sufficient to account for the pili defect in putrescine synthesis mutants. We conclude that pili synthesis requires putrescine and putrescine concentration is controlled by a complex homeostatic network that includes the genes of oxidative energy metabolism.

    1. Genetics and Genomics
    Yi Li, Long Gong ... Shangbang Gao
    Research Article

    Resistance to anthelmintics, particularly the macrocyclic lactone ivermectin (IVM), presents a substantial global challenge for parasite control. We found that the functional loss of an evolutionarily conserved E3 ubiquitin ligase, UBR-1, leads to IVM resistance in Caenorhabditis elegans. Multiple IVM-inhibiting activities, including viability, body size, pharyngeal pumping, and locomotion, were significantly ameliorated in various ubr-1 mutants. Interestingly, exogenous application of glutamate induces IVM resistance in wild-type animals. The sensitivity of all IVM-affected phenotypes of ubr-1 is restored by eliminating proteins associated with glutamate metabolism or signaling: GOT-1, a transaminase that converts aspartate to glutamate, and EAT-4, a vesicular glutamate transporter. We demonstrated that IVM-targeted GluCls (glutamate-gated chloride channels) are downregulated and that the IVM-mediated inhibition of serotonin-activated pharynx Ca2+ activity is diminished in ubr-1. Additionally, enhancing glutamate uptake in ubr-1 mutants through ceftriaxone completely restored their IVM sensitivity. Therefore, UBR-1 deficiency-mediated aberrant glutamate signaling leads to ivermectin resistance in C. elegans.